References
- Harrison TR, Peteredorf RG, eds. Harrison s principles of internal medicine. 10th ed. New York: McGraw-Hill. 1983: 1121–4
- Reuler JB, Chang MK. Herpes zoster: epidemiology, clinical features, and management. South Med J 1984: 77(9): 1149–56
- Ragozzino MW, Melton LJ 3d, Kurland LT, et al. Risk of cancer after herpes zoster: a population-based study. N Engl J Med 1982: 307(7): 393–7
- Ragozzino MW, Melton LJ 3d, Kurland LT, et al. Population-based study of herpes zoster and its sequelae. Medicine (Baltimore) 1982: 61 (5): 310–6
- Cecil RL, Wyngaarden JB, Smith LH, eds. Cecil textbook of medicine. 16th ed. Philadelphia: WB Saunders. 1982: 2092
- Womack LW, Liesegang TJ. Complications of herpes zoster ophthalmicus. Arch Ophthalmol 1983: 101(1): 42–5
- Marsh RJ. Current management of ophthalmic herpes zoster. Trans Ophthalmol Soc UK 1976: 96(2): 334–7
- Bean B, Braun C, Balfour HH Jr. Acyclovir therapy for acute herpes zoster. Lancet 1982: 2(8290): 118–21
- Balfour HH Jr, Bean B, Laskin OL, et al. Acyclovir halts progression of herpes zoster in immunocompromised patients. N Engl J Med 1983: 308(24): 1448–53
- Balfour HH Jr. Acyclovir therapy for herpes zoster: advantages and adverse effects. JAMA 1986: 255(3): 387–8
- McKendrick MW, Care C, Burke C, et al. Oral acyclovir in herpes zoster. J Antimicrob Chemother 1984: 14(6): 661–5
- McKendrick MW, McGill JI, White JE, et al. Oral acyclovir in acute herpes zoster. Br Med J 1986: 293(6561): 1529–32